Prognostic significance of circulating soluble programmed death ligand-1 in patients with solid tumors: a meta-analysis

被引：0
|
作者：
Wei, W.
Jiang, J.
机构：
[1] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou, Peoples R China
[2] Jiangsu Engn Res Ctr Tumor Immunotherapy, Changzhou, Peoples R China
[3] Soochow Univ, Inst Cell Therapy, Changzhou, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P3068
引用
收藏
页码：1583 / 1583
页数：1
相关论文
共 50 条
  • [21] Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis
    Piao, Jinlan
    Lim, Hyun Ji
    Lee, Maria
    OBSTETRICS & GYNECOLOGY SCIENCE, 2020, 63 (03) : 346 - 356
  • [22] Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis
    Xue Li
    Minghuan Li
    Zhen Lian
    Hui Zhu
    Li Kong
    Ping Wang
    Jinming Yu
    Targeted Oncology, 2016, 11 : 753 - 761
  • [23] Prognostic Value of Programmed Cell Death Ligand-1 Expression in Nasopharyngeal Carcinoma: A Meta-Analysis of 1,315 Patients
    Liu, Xiaofeng
    Shan, Chunguang
    Song, Yingluan
    Du, Juan
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [24] Prognostic prospect of soluble programmed cell death ligand-1 in cancer management
    Anwar, Nur Amira Khairil
    Nazri, Muhammad Najmi Mohd
    Murtadha, Ahmad Hafiz
    Adzemi, Elis Rosliza Mohd
    Balakrishnan, Venugopal
    Mustaffa, Khairul Mohd Fadzli
    Din, Tengku Ahmad Damitri Al-Astani Tengku
    Yahya, Maya Mazuwin
    Haron, Juhara
    Mokshtar, Noor Fatmawati
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 53 (08) : 961 - 978
  • [25] Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis
    Jun-shuai Xue
    Hui Liu
    Guang-Xiao Meng
    Zi-Niu Ding
    Lun-Jie Yan
    Sheng-Yu Yao
    Hai-Chao Li
    Zhao-Ru Dong
    Zhi-Qiang Chen
    Jian-Guo Hong
    Tao Li
    Cancer Immunology, Immunotherapy, 2022, 71 : 1633 - 1644
  • [26] Prognostic and clinicopathological value of soluble programmed cell death ligand-1 (sPD-L1) in patients with peripheral T-cell lymphoma: a meta-analysis
    Wu, Ying
    Zhang, Yan
    ANNALS OF MEDICINE, 2025, 57 (01)
  • [27] Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis
    Xue, Jun-Shuai
    Liu, Hui
    Meng, Guang-Xiao
    Ding, Zi-Niu
    Yan, Lun-Jie
    Yao, Sheng-Yu
    Li, Hai-Chao
    Dong, Zhao-Ru
    Chen, Zhi-Qiang
    Hong, Jian-Guo
    Li, Tao
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (07) : 1633 - 1644
  • [28] Prognostic role of programmed cell death ligand-1 expression in head and neck cancer treated with programmed cell death protein-1/programmed cell death ligand-1 inhibitors: A meta-analysis based on clinical trials
    Huang, Zilu
    Zheng, Shuohan
    Ding, Shirong
    Wei, Yinghong
    Chen, Chen
    Liu, Xing
    Li, He
    Xia, Yunfei
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (03) : 676 - 687
  • [29] The clinicopathological significance and prognostic value of programmed death-ligand 1 in prostate cancer: a meta-analysis of 3133 patients
    Shen, Haixiang
    Liu, Jin
    Sun, Guoliang
    Yan, Libin
    Li, Qinchen
    Wang, Zhize
    Xie, Liping
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 : 99 - 99
  • [30] Prognostic significance of programmed cell death ligand 1 expression in patients with ovarian carcinoma A systematic review and meta-analysis
    Huang, Li-Jun
    Deng, Xiao-Feng
    Chang, Fan
    Wu, Xian-Lan
    Wu, Yang
    Diao, Qi-Zhi
    MEDICINE, 2018, 97 (43)
12345